Dibucaine hydrochloride
[CAS# 61-12-1]

Identification

• Classification: API >> Anesthetic agents >> Local anesthetics
• Name: Dibucaine hydrochloride
• Synonyms: 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride; 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride
• Molecular Formula: C₂₀H₂₉N₃O₂^.HCl
• Molecular Weight: 379.93
• CAS Registry Number: 61-12-1
• EC Number: 200-498-1
• SMILES: CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.Cl

Properties

• Melting point: 99 - 101 ºC (Expl.)
• Solubility: DMSO 76 mg/mL, Water 76 mg/mL (Expl.)

Safety Data

• Hazard Symbols: GHS05;GHS07;GHS09 Danger
• Hazard Statements: H302-H317-H318-H411
• Precautionary Statements: P261-P264-P264+P265-P270-P272-P273-P280-P301+P317-P302+P352-P305+P354+P338-P317-P321-P330-P333+P317-P362+P364-P391-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Serious eye damage	Eye Dam.	1	H318
Acute toxicity	Acute Tox.	4	H302
Chronic hazardous to the aquatic environment	Aquatic Chronic	2	H411
Skin sensitization	Skin Sens.	1	H317
Acute toxicity	Acute Tox.	3	H301
Acute toxicity	Acute Tox.	3	H311
Skin irritation	Skin Irrit.	2	H315
Chronic hazardous to the aquatic environment	Aquatic Chronic	1	H410
Acute toxicity	Acute Tox.	2	H330
Specific target organ toxicity - single exposure	STOT SE	3	H335
Acute hazardous to the aquatic environment	Aquatic Acute	1	H400

Discovory and Applicatios

Dibucaine hydrochloride is a potent local anesthetic belonging to the amide class of anesthetics. It is primarily used for topical anesthesia of the skin and mucous membranes and occasionally in small doses for spinal anesthesia. Dibucaine hydrochloride exerts its anesthetic effect by blocking voltage-gated sodium channels in nerve cell membranes, thereby inhibiting the initiation and propagation of nerve impulses and causing a reversible loss of sensation in the area of application.

The compound was developed and introduced into clinical use in the mid-20th century, with its chemical structure designed to provide strong and long-lasting local anesthesia. Dibucaine hydrochloride is noted for its high potency compared to other local anesthetics, which makes it effective in very small amounts. It is commonly supplied as a hydrochloride salt to enhance its solubility and stability in aqueous formulations.

Clinically, dibucaine hydrochloride is often used in topical creams, ointments, or solutions for the relief of pain, itching, and discomfort associated with conditions such as hemorrhoids, minor burns, insect bites, and anal fissures. Its use in spinal anesthesia is limited due to concerns about neurotoxicity when used in higher concentrations or volumes.

Pharmacodynamically, dibucaine blocks the conduction of nerve impulses by selectively binding to and stabilizing the inactive state of sodium channels on neuronal membranes. This action prevents the influx of sodium ions necessary for depolarization, effectively blocking nerve signal transmission.

Pharmacokinetically, dibucaine hydrochloride is absorbed slowly from topical sites, which contributes to its prolonged duration of action. When absorbed systemically, it is metabolized primarily in the liver by enzymatic hydrolysis and N-dealkylation pathways. The metabolites and unchanged drug are excreted mainly via the kidneys. The elimination half-life varies depending on the route of administration but is generally several hours.

Adverse effects are primarily related to local irritation or allergic reactions at the site of application. Systemic toxicity is rare but can occur if excessive amounts are absorbed or injected, potentially causing symptoms such as dizziness, tinnitus, nervousness, seizures, or cardiac disturbances. Due to its potency, careful dosing and application are important to avoid toxicity.

Dibucaine hydrochloride is also known for its use in the dibucaine number test, a diagnostic assay to measure atypical plasma cholinesterase activity, which helps identify individuals with genetic variants that affect the metabolism of certain anesthetics.

In summary, dibucaine hydrochloride is a highly potent local anesthetic used primarily for topical pain relief. Its mechanism of action involves sodium channel blockade leading to nerve impulse inhibition. The compound’s strong anesthetic effect, coupled with a relatively slow systemic absorption and metabolism, allows for prolonged local anesthesia with a generally favorable safety profile when used appropriately.

References

1974. Kinetic characteristics of monoamine oxidase and serum cholinesterase in several related rat strains. Biochemical Genetics, 11(4).
DOI: 10.1007/bf00485998

2018. Greenness assessment as per Eco-scale and AMVI metrics for the chromatographic assay of selected drugs in a semisolid dosage form and in tissues. Chemical Papers, 73(3).
DOI: 10.1007/s11696-018-0619-z

2022. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2. The Journal of Biological Chemistry, 298(8).
DOI: 10.1016/j.jbc.2022.102228